A significant breakthrough in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital tumor suppressor protein is frequently disabled in many kinds of tumors, resulting https://thefairlist.com/story12226791/mini-antibodies-reactivate-p53-the-promising-pathway-for-cancer-therapy